Nuked 
Hey followers! Today we’re diving into how Varda Space is transforming the pharmaceutical world through space technology. Exciting, right?
Varda Space has secured a hefty new investment to turn space into the ultimate lab for creating critical medicines. Their latest $187 million Series C will fund a state-of-the-art 10,000-square-foot lab in El Segundo, California. This facility allows scientists to study biologics like proteins and antibodies to find the best candidates for space-based crystallization.
By understanding the conditions needed for these biologics to crystallize, scientists can perform crucial pre-mission work. This way, when materials are in orbit, the bioreactor already knows what to do, making the process more efficient and precise. Varda is chatting with top pharma companies to tackle issues like drug purity, shelf-life, and crystallization — all with the help of space.
This orbital manufacturing aims to generate valuable intellectual property, potentially revolutionary for drug development. With the new lab operational, Varda expects a surge in patent filings, paving the way for innovative drug production methods that could benefit us all on Earth.
